Late-stage trial data for Roche’s drug against muscle-wasting Elevidys showed positive results after two years of treatment for male patients aged 4 or older with Duchenne muscular dystrophy. The data ...
Add Yahoo as a preferred source to see more of our stories on Google. This image from video provided by UPMC and University of Pittsburgh Health Sciences shows Doug McCullough, who has spinal muscular ...
Dr. Diana Castro (left) checks Hudson Sanford’s, a young boy with Duchenne muscular dystrophy traveling from Arizona, heartbeat before he is dosed with ELEVIDYS at the Neurology & Neuromuscular Care ...
Researchers have identified a protein that’s critical to the development of skeletal muscle mass and strength and the tissue’s ability to metabolize glucose. They say their findings may lead to ...
WASHINGTON (AP) — Three people with a muscle-destroying disease destined to worsen got a little stronger – able to stand and walk more easily – when an implanted device zapped their spinal cord. On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results